Cargando…
Structure and Function of SET and MYND Domain-Containing Proteins
SET (Suppressor of variegation, Enhancer of Zeste, Trithorax) and MYND (Myeloid-Nervy-DEAF1) domain-containing proteins (SMYD) have been found to methylate a variety of histone and non-histone targets which contribute to their various roles in cell regulation including chromatin remodeling, transcri...
Autores principales: | Spellmon, Nicholas, Holcomb, Joshua, Trescott, Laura, Sirinupong, Nualpun, Yang, Zhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307310/ https://www.ncbi.nlm.nih.gov/pubmed/25580534 http://dx.doi.org/10.3390/ijms16011406 |
Ejemplares similares
-
Mechanistic and functional extrapolation of SET and MYND domain-containing protein 2 to pancreatic cancer
por: Alshammari, Eid, et al.
Publicado: (2022) -
Molecular Dynamics Simulation Reveals Correlated Inter-Lobe Motion in Protein Lysine Methyltransferase SMYD2
por: Spellmon, Nicholas, et al.
Publicado: (2015) -
New open conformation of SMYD3 implicates conformational selection and allostery
por: Spellmon, Nicholas, et al.
Publicado: (2016) -
SET and MYND domain-containing protein 3 inhibits tumor cell sensitivity to cisplatin
por: Wang, Lei, et al.
Publicado: (2020) -
Crystal Structures of Histone and p53 Methyltransferase SmyD2 Reveal a Conformational Flexibility of the Autoinhibitory C-Terminal Domain
por: Jiang, Yuanyuan, et al.
Publicado: (2011)